Evolutionary Tree Capital Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Evolutionary Tree Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$169.75 - $207.73 $5.07 Million - $6.2 Million	-29,870 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$128.63 - $176.89 $1.5 Million - $2.06 Million	-11,667 Reduced 28.09%	29,870 $5.06 Million
Q1 2021 May 14, 2021	BUY	$126.83 - $175.69 $1.53 Million - $2.11 Million	12,029 Added 40.77%	41,537 $5.87 Million
Q4 2020 Feb 10, 2021	BUY	$122.97 - $147.0 $3.63 Million - $4.34 Million	29,508 New	29,508 $3.84 Million

642

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Evolutionary Tree Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolutionary Tree Capital Management, LLC with notifications on news.